IL2 and neoplasm: Flow cytometric analysis of tumor-infiltrating lymphocytes revealed that administration of IFN-γ and IL-2 downregulated the expression of CTLA-4 on CD3+ CD8+ TILs compared to control groups on day 14 post-transfer (Fig 6A).